Trial intelligence / Profile preview

Levocetirizine vs Loratadine in Chronic Idiopathic Urticaria

NCT00525382Phase 3Completed

Sponsor
UCB
Start
Aug 2003
Primary completion
Mar 2004
Modality
Small Molecules
01

Overview

A Phase 3 trial of levocetirizine in chronic idiopathic urticaria (CIU), sponsored by UCB. Started Aug 2003; status: completed.

02

Drugs

levocetirizine
03

Conditions

chronic idiopathic urticaria (CIU)

Beyond the preview

Go deeper on NCT00525382.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00525382.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call